DEVELOPMENTAL FUNDS: ABSTRACT Developmental Funds of $50,000 are requested to provide an essential foundation of support for the Cancer Center's investment in emerging scientific and technological opportunities. As part of the planning and evaluation process, KCI links its strategic objectives with programmatic priorities and targets funding to specific developmental goals in: 1) support of innovative pilot projects; 2) recruitment of faculty-level scientists; 3) development of programs that train researchers and sustain a vigorous portfolio of external funding; 4) support of developing Shared Resources; and 5) providing Core vouchers that encourage the use of Cancer Center Shared Resources by junior faculty and those wishing to explore innovative, otherwise unfunded research. CCSG Developmental Funds During the period of 12/1/2010 to 5/31/2014, three developing Shared Resources were supported with $187,372 of CCSG Developmental Funds: Animal Model and Therapeutics Evaluation Core (AMTEC), Translational Sciences Core (TSC), and Clinical Imaging Research Core (CIRC). The AMTEC developing Core is being submitted as a new, full Core in this competing renewal application. The TSC developing Core is being integrated into the Biorepository Core (which has been re-named Biobanking and Correlative Sciences Core). The CIRC has been discontinued as a developing Core with the concurrence of our EAB. WSU/KCI Institutional Support for Developmental Fund Activities During the period of 12/1/2010 to 5/31/2014, institutional support provided a total of $11.5 million in funds. With the use of these funds, the Cancer Center has achieved a remarkable return on investment: ? Investing in annual pilot funding for innovative projects. A total of $985,232 was invested in pilot projects, yielding eleven extramural awards, totaling $9,989,542. ? Supporting the recruitment of faculty level scientists. A total of $7,918,013 was provided from a combination of KCI and WSU institutional support for 42 new faculty members' salaries and lab support during the past three-and-a-half years. These new faculty level scientists have generated a total of 211 publications, 32 grant awards, and 85 clinical trials since their arrival. ? Establishing a post-doctoral research training program. A total of $215,908 supported 8 post-doctoral fellows, resulting in the recruitment of one faculty level scientist. ? Creating a mock study section program. A total of $5,400 in stipends to reviewers was provided from institutional support, resulting in $1,580,044 of extramural funding. ? Nurturing three new Shared Resources. A total of $2,330,214 was provided from institutional support.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA022453-37
Application #
9605737
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2018-12-01
Budget End
2019-11-30
Support Year
37
Fiscal Year
2019
Total Cost
Indirect Cost
Name
Wayne State University
Department
Type
DUNS #
001962224
City
Detroit
State
MI
Country
United States
Zip Code
48202
Bock, Cathryn H; Jay, Allison M; Dyson, Gregory et al. (2018) The effect of genetic variants on the relationship between statins and breast cancer in postmenopausal women in the Women's Health Initiative observational study. Breast Cancer Res Treat 167:741-749
Hastert, T A; de Oliveira Otto, M C; LĂȘ-Scherban, F et al. (2018) Association of plasma phospholipid polyunsaturated and trans fatty acids with body mass index: results from the Multi-Ethnic Study of Atherosclerosis. Int J Obes (Lond) 42:433-440
Heyza, Joshua; Lei, Wen; Watza, Donovan et al. (2018) Identification and characterization of synthetic viability with ERCC1 deficiency in response to interstrand crosslinks in lung cancer. Clin Cancer Res :
Mittal, Sandeep; Klinger, Neil V; Michelhaugh, Sharon K et al. (2018) Alternating electric tumor treating fields for treatment of glioblastoma: rationale, preclinical, and clinical studies. J Neurosurg 128:414-421
Park, Hyo K; Schildkraut, Joellen M; Alberg, Anthony J et al. (2018) Benign gynecologic conditions are associated with ovarian cancer risk in African-American women: a case-control study. Cancer Causes Control 29:1081-1091
Su, Yongwei; Li, Xinyu; Ma, Jun et al. (2018) Targeting PI3K, mTOR, ERK, and Bcl-2 signaling network shows superior antileukemic activity against AML ex vivo. Biochem Pharmacol 148:13-26
Bonomi, Robin; Popov, Vadim; Laws, Maxwell T et al. (2018) Molecular Imaging of Sirtuin1 Expression-Activity in Rat Brain Using Positron-Emission Tomography-Magnetic-Resonance Imaging with [18F]-2-Fluorobenzoylaminohexanoicanilide. J Med Chem 61:7116-7130
Paximadis, Peter; Beebe-Dimmer, Jennifer L; George, Julie et al. (2018) Comparing Treatment Strategies for Stage I Small-cell lung Cancer. Clin Lung Cancer 19:e559-e565
Modi, Dipenkumar; Al-Kadhimi, Zaid; Chen, Wei et al. (2018) A phase II study of tacrolimus and thymoglobulin as graft-versus-host-disease prophylaxis in related donor allogeneic hematopoietic cell transplantation. Am J Hematol 93:E96-E98
Patki, Mugdha; McFall, Thomas; Rosati, Rayna et al. (2018) Chronic p27Kip1 Induction by Dexamethasone Causes Senescence Phenotype and Permanent Cell Cycle Blockade in Lung Adenocarcinoma Cells Over-expressing Glucocorticoid Receptor. Sci Rep 8:16006

Showing the most recent 10 out of 826 publications